Global Computer-assisted Drug Design Platform Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI04241216

Publication Date:

April 8, 2024

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Computer-assisted Drug Design Platform market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
publisher' newest research report, the 鈥淐omputer-assisted Drug Design Platform Industry Forecast鈥� looks at past sales and reviews total world Computer-assisted Drug Design Platform sales in 2023, providing a comprehensive analysis by region and market sector of projected Computer-assisted Drug Design Platform sales for 2024 through 2030. With Computer-assisted Drug Design Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Computer-assisted Drug Design Platform industry.
This Insight Report provides a comprehensive analysis of the global Computer-assisted Drug Design Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Computer-assisted Drug Design Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Computer-assisted Drug Design Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Computer-assisted Drug Design Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Computer-assisted Drug Design Platform.
United States market for Computer-assisted Drug Design Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Computer-assisted Drug Design Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Computer-assisted Drug Design Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Computer-assisted Drug Design Platform players cover Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics and Schrodinger, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Computer-assisted Drug Design Platform market by product type, application, key players and key regions and countries.
Segmentation by type
Cloud-based
On-premise
Segmentation by application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Computer-assisted Drug Design Platform Market Size 2019-2030
2.1.2 Computer-assisted Drug Design Platform Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Computer-assisted Drug Design Platform Segment by Type
2.2.1 Cloud-based
2.2.2 On-premise
2.3 Computer-assisted Drug Design Platform Market Size by Type
2.3.1 Computer-assisted Drug Design Platform Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Computer-assisted Drug Design Platform Market Size Market Share by Type (2019-2024)
2.4 Computer-assisted Drug Design Platform Segment by Application
2.4.1 Drug Discovery and Development
2.4.2 Computational Physiological Medicine
2.4.3 Disease Modeling
2.4.4 Medical Imaging
2.4.5 Predictive Analysis of Drug Targets
2.5 Computer-assisted Drug Design Platform Market Size by Application
2.5.1 Computer-assisted Drug Design Platform Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Computer-assisted Drug Design Platform Market Size Market Share by Application (2019-2024)
3 Computer-assisted Drug Design Platform Market Size by Player
3.1 Computer-assisted Drug Design Platform Market Size Market Share by Players
3.1.1 Global Computer-assisted Drug Design Platform Revenue by Players (2019-2024)
3.1.2 Global Computer-assisted Drug Design Platform Revenue Market Share by Players (2019-2024)
3.2 Global Computer-assisted Drug Design Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Computer-assisted Drug Design Platform by Regions
4.1 Computer-assisted Drug Design Platform Market Size by Regions (2019-2024)
4.2 Americas Computer-assisted Drug Design Platform Market Size Growth (2019-2024)
4.3 APAC Computer-assisted Drug Design Platform Market Size Growth (2019-2024)
4.4 Europe Computer-assisted Drug Design Platform Market Size Growth (2019-2024)
4.5 Middle East & Africa Computer-assisted Drug Design Platform Market Size Growth (2019-2024)
5 Americas
5.1 Americas Computer-assisted Drug Design Platform Market Size by Country (2019-2024)
5.2 Americas Computer-assisted Drug Design Platform Market Size by Type (2019-2024)
5.3 Americas Computer-assisted Drug Design Platform Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Computer-assisted Drug Design Platform Market Size by Region (2019-2024)
6.2 APAC Computer-assisted Drug Design Platform Market Size by Type (2019-2024)
6.3 APAC Computer-assisted Drug Design Platform Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Computer-assisted Drug Design Platform by Country (2019-2024)
7.2 Europe Computer-assisted Drug Design Platform Market Size by Type (2019-2024)
7.3 Europe Computer-assisted Drug Design Platform Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Computer-assisted Drug Design Platform by Region (2019-2024)
8.2 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Type (2019-2024)
8.3 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Computer-assisted Drug Design Platform Market Forecast
10.1 Global Computer-assisted Drug Design Platform Forecast by Regions (2025-2030)
10.1.1 Global Computer-assisted Drug Design Platform Forecast by Regions (2025-2030)
10.1.2 Americas Computer-assisted Drug Design Platform Forecast
10.1.3 APAC Computer-assisted Drug Design Platform Forecast
10.1.4 Europe Computer-assisted Drug Design Platform Forecast
10.1.5 Middle East & Africa Computer-assisted Drug Design Platform Forecast
10.2 Americas Computer-assisted Drug Design Platform Forecast by Country (2025-2030)
10.2.1 United States Computer-assisted Drug Design Platform Market Forecast
10.2.2 Canada Computer-assisted Drug Design Platform Market Forecast
10.2.3 Mexico Computer-assisted Drug Design Platform Market Forecast
10.2.4 Brazil Computer-assisted Drug Design Platform Market Forecast
10.3 APAC Computer-assisted Drug Design Platform Forecast by Region (2025-2030)
10.3.1 China Computer-assisted Drug Design Platform Market Forecast
10.3.2 Japan Computer-assisted Drug Design Platform Market Forecast
10.3.3 Korea Computer-assisted Drug Design Platform Market Forecast
10.3.4 Southeast Asia Computer-assisted Drug Design Platform Market Forecast
10.3.5 India Computer-assisted Drug Design Platform Market Forecast
10.3.6 Australia Computer-assisted Drug Design Platform Market Forecast
10.4 Europe Computer-assisted Drug Design Platform Forecast by Country (2025-2030)
10.4.1 Germany Computer-assisted Drug Design Platform Market Forecast
10.4.2 France Computer-assisted Drug Design Platform Market Forecast
10.4.3 UK Computer-assisted Drug Design Platform Market Forecast
10.4.4 Italy Computer-assisted Drug Design Platform Market Forecast
10.4.5 Russia Computer-assisted Drug Design Platform Market Forecast
10.5 Middle East & Africa Computer-assisted Drug Design Platform Forecast by Region (2025-2030)
10.5.1 Egypt Computer-assisted Drug Design Platform Market Forecast
10.5.2 South Africa Computer-assisted Drug Design Platform Market Forecast
10.5.3 Israel Computer-assisted Drug Design Platform Market Forecast
10.5.4 Turkey Computer-assisted Drug Design Platform Market Forecast
10.5.5 GCC Countries Computer-assisted Drug Design Platform Market Forecast
10.6 Global Computer-assisted Drug Design Platform Forecast by Type (2025-2030)
10.7 Global Computer-assisted Drug Design Platform Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Entelos
11.1.1 Entelos Company Information
11.1.2 Entelos Computer-assisted Drug Design Platform Product Offered
11.1.3 Entelos Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Entelos Main Business Overview
11.1.5 Entelos Latest Developments
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Information
11.2.2 Crown Bioscience Computer-assisted Drug Design Platform Product Offered
11.2.3 Crown Bioscience Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Crown Bioscience Main Business Overview
11.2.5 Crown Bioscience Latest Developments
11.3 Chemical Computing Group
11.3.1 Chemical Computing Group Company Information
11.3.2 Chemical Computing Group Computer-assisted Drug Design Platform Product Offered
11.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Chemical Computing Group Main Business Overview
11.3.5 Chemical Computing Group Latest Developments
11.4 Nimbus Therapeutics
11.4.1 Nimbus Therapeutics Company Information
11.4.2 Nimbus Therapeutics Computer-assisted Drug Design Platform Product Offered
11.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Nimbus Therapeutics Main Business Overview
11.4.5 Nimbus Therapeutics Latest Developments
11.5 Schrodinger
11.5.1 Schrodinger Company Information
11.5.2 Schrodinger Computer-assisted Drug Design Platform Product Offered
11.5.3 Schrodinger Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Schrodinger Main Business Overview
11.5.5 Schrodinger Latest Developments
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Information
11.6.2 Dassault Systemes Computer-assisted Drug Design Platform Product Offered
11.6.3 Dassault Systemes Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dassault Systemes Main Business Overview
11.6.5 Dassault Systemes Latest Developments
11.7 Genedata
11.7.1 Genedata Company Information
11.7.2 Genedata Computer-assisted Drug Design Platform Product Offered
11.7.3 Genedata Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genedata Main Business Overview
11.7.5 Genedata Latest Developments
11.8 Biognos
11.8.1 Biognos Company Information
11.8.2 Biognos Computer-assisted Drug Design Platform Product Offered
11.8.3 Biognos Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Biognos Main Business Overview
11.8.5 Biognos Latest Developments
11.9 Leadscope
11.9.1 Leadscope Company Information
11.9.2 Leadscope Computer-assisted Drug Design Platform Product Offered
11.9.3 Leadscope Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Leadscope Main Business Overview
11.9.5 Leadscope Latest Developments
11.10 Rhenovia Pharma Limited
11.10.1 Rhenovia Pharma Limited Company Information
11.10.2 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Offered
11.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rhenovia Pharma Limited Main Business Overview
11.10.5 Rhenovia Pharma Limited Latest Developments
11.11 Compugen
11.11.1 Compugen Company Information
11.11.2 Compugen Computer-assisted Drug Design Platform Product Offered
11.11.3 Compugen Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Compugen Main Business Overview
11.11.5 Compugen Latest Developments
11.12 Certara LP
11.12.1 Certara LP Company Information
11.12.2 Certara LP Computer-assisted Drug Design Platform Product Offered
11.12.3 Certara LP Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Certara LP Main Business Overview
11.12.5 Certara LP Latest Developments
11.13 Prosarix
11.13.1 Prosarix Company Information
11.13.2 Prosarix Computer-assisted Drug Design Platform Product Offered
11.13.3 Prosarix Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Prosarix Main Business Overview
11.13.5 Prosarix Latest Developments
11.14 Simulations Plus
11.14.1 Simulations Plus Company Information
11.14.2 Simulations Plus Computer-assisted Drug Design Platform Product Offered
11.14.3 Simulations Plus Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Simulations Plus Main Business Overview
11.14.5 Simulations Plus Latest Developments
11.15 Strand Life Sciences
11.15.1 Strand Life Sciences Company Information
11.15.2 Strand Life Sciences Computer-assisted Drug Design Platform Product Offered
11.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Strand Life Sciences Main Business Overview
11.15.5 Strand Life Sciences Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂